Insider Sale by Cox John (CEO & President)
Trade Summary
2 days ago, Cox John, serving as CEO & President at Dyne Therapeutics, Inc. (DYN), sold 5,658 shares at $18.88 per share, for a total transaction value of $106,823.04. Following this transaction, Cox John now holds 357,507 shares of DYN.
This sale represents a 1.56% decrease in Cox John's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:13 PM ET, meaning the disclosure happened on the same day as the trade.
Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$18.88
Quantity
5,658
Total Value
$106,823.04
Shares Owned
357,507
Trade Date
2 days ago
SEC Filing Date
at 4:13 PM ET
Discussion